OraSure OTC HIV Test To Enter Phase II Trials By Summer
This article was originally published in The Tan Sheet
Executive Summary
HIV test kit manufacturer OraSure Technologies should be required to conduct actual-use studies as part of Phase III trial commitments, according to an FDA advisory panel
You may also be interested in...
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30